NCT06437080 - Hypoferritinemia Without Anemia Among Reproductive Age Females | Biotech Hunter

Enrollment

1,331

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions

Hypoferritenemia Without Anemia (HWA)Iron Deficiency Without Anemia)

Interventions

DRUG

Iron III Hydroxide Polymaltose Complex eq. to Elemental Iron, 100 mg

01 tablet daily for 03 months, This is assigned to Group A.

DRUG

Ferric Carboxymaltose

03 doses (50 mg iron/mL) per month for 03 months. This is assigned to Group B.

Trial Locations (4)

Fatima Memorial Hospital, Lahore

General Hospital Lahore, Lahore

Gulab Devi Hospital, Lahore

Sir Gangaram Hospital, Lahore